Spectral AI Inc (MDAI)

Currency in USD
2.430
+0.030(+1.25%)
Real-time Data·
MDAI Scorecard
Full Analysis
2 analysts have revised their earnings upwards for the upcoming period
MDAI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.3752.490
52 wk Range
0.8243.250
Key Statistics
Prev. Close
2.4
Open
2.4
Day's Range
2.375-2.49
52 wk Range
0.824-3.25
Volume
106.96K
Average Volume (3m)
513.12K
1-Year Change
70.21%
Book Value / Share
-0.06
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MDAI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.090
Upside
+109.47%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Spectral AI Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Spectral AI Inc Company Profile

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.

Spectral AI Inc Earnings Call Summary for Q4/2024

  • Record R&D revenue of $29.6M in 2024, up 63.5% YoY; gross margins improved to 44.9%
  • Preparing for FDA submission, targeting clearance in 2026; forecasts $21.5M revenue for FY2025
  • Plans to spin off intellectual property subsidiary, Spectral IP; stock up 2.34% in aftermarket trading
  • DeepView system outperformed clinician assessments in burn care; Snapshot M tool deployment expected in 2027
  • Cash position strengthened to over $14M post-financing; analysts maintain strong buy consensus
Last Updated: 27/03/2025, 22:52
Read Full Transcript

Compare MDAI to Peers and Sector

Metrics to compare
MDAI
Peers
Sector
Relationship
P/E Ratio
−6.7x−3.5x−0.5x
PEG Ratio
−0.11−0.190.00
Price/Book
−37.8x2.5x2.6x
Price / LTM Sales
2.1x3.3x3.3x
Upside (Analyst Target)
103.7%26.2%43.4%
Fair Value Upside
Unlock8.0%7.1%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 5.090
(+109.47% Upside)

Earnings

Latest Release
May 15, 2025
EPS / Forecast
0.11 / -0.41
Revenue / Forecast
6.71M / 6.30M
EPS Revisions
Last 90 days

MDAI Income Statement

People Also Watch

3.499
ONDS
+7.67%
248.87
AVAV
-4.14%
47.240
ASTS
-0.99%
15.49
OSCR
+2.18%
9.987
UMAC
+4.14%

FAQ

What Stock Exchange Does Spectral AI Trade On?

Spectral AI is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Spectral AI?

The stock symbol for Spectral AI is "MDAI."

What Is the Spectral AI Market Cap?

As of today, Spectral AI market cap is 62.05M.

What Is Spectral AI's Earnings Per Share (TTM)?

The Spectral AI EPS (TTM) is -0.47.

From a Technical Analysis Perspective, Is MDAI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Spectral AI Stock Split?

Spectral AI has split 0 times.

How Many Employees Does Spectral AI Have?

Spectral AI has 78 employees.

What is the current trading status of Spectral AI (MDAI)?

As of 08 Aug 2025, Spectral AI (MDAI) is trading at a price of 2.43, with a previous close of 2.40. The stock has fluctuated within a day range of 2.38 to 2.49, while its 52-week range spans from 0.82 to 3.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.